Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 98430957 | 9843095 | 7 | F | 201112 | 20160901 | 20140124 | 20160906 | EXP | GB-ABBVIE-12P-167-0955187-00 | ABBVIE | 52.59 | YR | M | Y | 58.20000 | KG | 20160906 | OT | COUNTRY NOT SPECIFIED | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 98430957 | 9843095 | 1 | PS | HUMIRA | ADALIMUMAB | 1 | Subcutaneous | UNKNOWN | 125057 | 40 | MG | SOLUTION FOR INJECTION | QOW | ||||||
| 98430957 | 9843095 | 2 | C | HALF-INDERAL LA | 2 | 0 | |||||||||||||
| 98430957 | 9843095 | 3 | C | LANSOPRAZOLE. | LANSOPRAZOLE | 1 | 0 | ||||||||||||
| 98430957 | 9843095 | 4 | C | DOCUSATE SODIUM. | DOCUSATE SODIUM | 1 | 0 | ||||||||||||
| 98430957 | 9843095 | 5 | C | DEXAMETHASONE. | DEXAMETHASONE | 1 | 0 | ||||||||||||
| 98430957 | 9843095 | 6 | C | OCTREOTIDE. | OCTREOTIDE | 1 | 0 | ||||||||||||
| 98430957 | 9843095 | 7 | C | CYCLIZINE | CYCLIZINE | 1 | 0 | ||||||||||||
| 98430957 | 9843095 | 8 | C | HYOSCINE BUTYLBROMIDE | BUTYLSCOPOLAMINE | 1 | 0 | ||||||||||||
| 98430957 | 9843095 | 9 | C | LEVOMEPROMAZINE | LEVOMEPROMAZINE | 1 | 0 | ||||||||||||
| 98430957 | 9843095 | 10 | C | OXYCODONE | OXYCODONE | 1 | 0 | ||||||||||||
| 98430957 | 9843095 | 11 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | 0 | ||||||||||||
| 98430957 | 9843095 | 12 | C | MOVICOL | POLYETHYLENE GLYCOL 3350POTASSIUM CHLORIDESODIUM BICARBONATESODIUM CHLORIDE | 1 | 0 | ||||||||||||
| 98430957 | 9843095 | 13 | C | ERYTHROMYCIN. | ERYTHROMYCIN | 1 | 0 | ||||||||||||
| 98430957 | 9843095 | 14 | C | LORAZEPAM. | LORAZEPAM | 1 | 0 | ||||||||||||
| 98430957 | 9843095 | 15 | C | PARACETAMOL | ACETAMINOPHEN | 1 | 0 | ||||||||||||
| 98430957 | 9843095 | 16 | C | METOCLOPRAMIDE. | METOCLOPRAMIDE | 1 | 0 | ||||||||||||
| 98430957 | 9843095 | 17 | C | HALOPERIDOL. | HALOPERIDOL | 1 | 0 | ||||||||||||
| 98430957 | 9843095 | 18 | C | BUSCOPAN | BUTYLSCOPOLAMINE BROMIDE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 98430957 | 9843095 | 1 | Psoriasis |
| 98430957 | 9843095 | 2 | Product used for unknown indication |
| 98430957 | 9843095 | 3 | Product used for unknown indication |
| 98430957 | 9843095 | 4 | Product used for unknown indication |
| 98430957 | 9843095 | 5 | Product used for unknown indication |
| 98430957 | 9843095 | 6 | Product used for unknown indication |
| 98430957 | 9843095 | 7 | Product used for unknown indication |
| 98430957 | 9843095 | 8 | Product used for unknown indication |
| 98430957 | 9843095 | 9 | Product used for unknown indication |
| 98430957 | 9843095 | 10 | Product used for unknown indication |
| 98430957 | 9843095 | 11 | Product used for unknown indication |
| 98430957 | 9843095 | 12 | Product used for unknown indication |
| 98430957 | 9843095 | 13 | Product used for unknown indication |
| 98430957 | 9843095 | 14 | Product used for unknown indication |
| 98430957 | 9843095 | 15 | Product used for unknown indication |
| 98430957 | 9843095 | 16 | Product used for unknown indication |
| 98430957 | 9843095 | 17 | Product used for unknown indication |
| 98430957 | 9843095 | 18 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 98430957 | 9843095 | DE |
| 98430957 | 9843095 | OT |
| 98430957 | 9843095 | LT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 98430957 | 9843095 | Abdominal pain | |
| 98430957 | 9843095 | Adenocarcinoma gastric | |
| 98430957 | 9843095 | Anastomotic stenosis | |
| 98430957 | 9843095 | Dyspepsia | |
| 98430957 | 9843095 | Eructation | |
| 98430957 | 9843095 | Gastric dilatation | |
| 98430957 | 9843095 | General physical health deterioration | |
| 98430957 | 9843095 | Hiccups | |
| 98430957 | 9843095 | Intestinal dilatation | |
| 98430957 | 9843095 | Metastatic gastric cancer | |
| 98430957 | 9843095 | Metastatic neoplasm | |
| 98430957 | 9843095 | Nausea | |
| 98430957 | 9843095 | Neoplasm recurrence | |
| 98430957 | 9843095 | Pelvic adhesions | |
| 98430957 | 9843095 | Small intestinal obstruction | |
| 98430957 | 9843095 | Vomiting | |
| 98430957 | 9843095 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 98430957 | 9843095 | 1 | 20100928 | 20101025 | 0 | |
| 98430957 | 9843095 | 2 | 20080228 | 0 | ||
| 98430957 | 9843095 | 3 | 20120601 | 0 | ||
| 98430957 | 9843095 | 4 | 20120601 | 0 | ||
| 98430957 | 9843095 | 5 | 20120601 | 0 | ||
| 98430957 | 9843095 | 6 | 20120601 | 0 | ||
| 98430957 | 9843095 | 7 | 20120601 | 0 | ||
| 98430957 | 9843095 | 8 | 20120601 | 0 | ||
| 98430957 | 9843095 | 9 | 20120601 | 0 | ||
| 98430957 | 9843095 | 10 | 20120613 | 20120830 | 0 | |
| 98430957 | 9843095 | 11 | 20120607 | 0 | ||
| 98430957 | 9843095 | 12 | 20120607 | 0 | ||
| 98430957 | 9843095 | 13 | 20120607 | 0 | ||
| 98430957 | 9843095 | 14 | 20120607 | 0 | ||
| 98430957 | 9843095 | 15 | 20120607 | 0 | ||
| 98430957 | 9843095 | 16 | 20120702 | 0 | ||
| 98430957 | 9843095 | 17 | 20120712 | 0 | ||
| 98430957 | 9843095 | 18 | 20120817 | 0 |